Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The market for sacroiliitis is growing because more and more people are getting it, especially older people.
MRI and CT scans are getting better, which helps doctors find sacroiliitis earlier and more correctly, which grows the market.
As more healthcare workers and people learn about sacroiliitis, it can be found and treated early, which has helped the market grow.
The market is growing because pharmaceutical companies are investing much in sacroiliitis research.
Biologic medications like TNF and IL inhibitors dominate the sacroiliitis market since they treat symptoms and extend the condition.
NSAIDs are the most common sacroiliitis therapy since they're cheap and simple to buy.
More people are using physical therapy and exercise to treat sacroiliitis for pain and mobility. Successful therapies create demand, changing the market.
The market is increasing because rising healthcare expenses make more sophisticated sacroiliitis therapies simpler to acquire, particularly in industrialized nations.
Biosimilars for sacroiliitis provide cheaper alternatives to biologic therapies, expanding the market and patient base.
Pharmaceutical corporations, healthcare providers, and patient support organizations are collaborating to spread the word, make medication more accessible, and better research to boost market trends.
Healthcare and treatment options vary by region, which affects the business and allows market actors to supply unmet requirements in underdeveloped areas. Regulatory changes, such as rules on medication reviews and payment, affect market trends and how well new sacroiliitis treatments are received.
Access to sacroiliitis doctors and medicines has gotten better thanks to telemedicine and remote healthcare services, especially during the COVID-19 outbreak. This has slowed the growth of the market.
In the sacroiliitis business, personalized treatment and all-around care are becoming more common. This shift affects new ideas and changes in the market.
The industry is ready to grow thanks to research, new technologies, and information about sacroiliitis. This raise means the market will grow and patient results will get better.
Sacroiliitis Market Highlights:
Sacroiliitis Market Overview
The Sacroiliitis Market is projected to reach USD 0.65 Billion by 2030 at 19.10% CAGR during the forecast period 2022-2030. Sacroiliitis is a medical condition where there is inflammation in one or both sacroiliac joints situated in the pelvis and lower back. The function of a sacroiliac joint is to bear the weight of the upper body while standing, walking, and others.
The condition can be diagnosed by imaging techniques. Sacroiliitis is caused due to traumatic injury, arthritis, pregnancy, infection, spondylitis, and others. The increasing prevalence of arthritis is the key factor for the market growth. According to the Centers for Disease Control and Prevention (2013to 2015), 22.7% Americans of the total population had arthritis, annually. Thus, such a high prevalence of arthritis and increasing government funding for the healthcare sector enhance the growth of this market.
However, factors such as expensive diagnostic tests and the high cost of surgical procedures are expected to restrict the market growth during the forecast period.
Sacroiliitis Market Segmentation
The sacroiliitis market is segmented on the basis of diagnosis, treatment, and end-user. The sacroiliitis industry, by diagnosis, is sub-segmented into imaging tests and anesthetic injections. The imaging tests category includes x-ray, MRI, and CT scan.
On the basis of treatment, the market is categorized into medications, joint injections, radiofrequency denervation, electrical stimulation, joint fusion, facet block, chiropractic manipulation, and physical therapy.
On the basis of end-user, the market is segmented into hospitals and clinics, pharmacies, and diagnostic centers.
On the basis of region, the sacroiliitis market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe.
The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.
Some of the key players in the sacroiliitis market are Medacta International, SI-BONE, Globus Medical, Zyga Technology, Nutech Medical, CoorsTek Medical LLC, Aspen Medical Products, Medtronic, and others.
Sacroiliitis Market Regional Analysis
The sacroiliitis market is dominated by North America owing to the high prevalence of arthritis and high healthcare investments within this region. According to the Centers for Disease Control and Prevention by 2040, 78.4 million will have doctor-diagnosed arthritis.
The rising adoption of technologically advanced systems for early diagnosis of diseases also drives the market growth in this region.
It is estimated that Europe stood second in the sacroiliitis market. The increasing prevalence of lower back disorders and the availability of minimally invasive surgical procedures for sacroiliitis drive the market growth in this region. According to The European (2015), sacroiliac joint was the main reason for chronic low back pain in Europe.
Asia-Pacific was projected to be the fastest growing region for the sacroiliitis market. Key factors such as the growing patient pool, the high prevalence of chronic diseases, developing healthcare infrastructure, and increasing research and development activities in the biotechnology sector influence the market in this region. The presence of major market players such as China, India, and Japan drives the market growth.
The Middle East and Africa holds the least share of the sacroiliitis market due to the presence of stringent government policies and poor economies. However, growing awareness among the population, rising government initiatives to improve the healthcare sector, and high investments by private market players in this region can boost the market growth.
Intended Audience
- Pharmaceutical companies
- Biotechnological institutes
- Government and private laboratories
- Research and Development (R&D) companies
- Medical research laboratories
- Market research and consulting service providers
Market Segmentation and Key Market Players
Sacroiliitis Market, by Diagnosis
- Imaging tests
- X-ray
- MRI
- CT scan
- Anesthetic injections
Sacroiliitis Market, by Treatment
- Medications
- Pain relievers
- Muscle relaxants
- TNF inhibitors
- Joint injections
- Radiofrequency denervation
- Electrical stimulation
- Joint fusion
- Facet block
- Chiropractic manipulation
- Physical therapy
Sacroiliitis Market, by End-User
- Hospitals & Clinics
- Pharmacies
- Diagnostic Centers
Sacroiliitis Market, by Region
- Americas
- Europe
- Asia-Pacific
- Middle East & Africa
Sacroiliitis Market, by Key Players
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
